Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 3
2005 2
2006 6
2007 9
2008 9
2009 11
2010 9
2011 9
2012 13
2013 10
2014 10
2015 14
2016 15
2017 17
2018 12
2019 11
2020 18
2021 11
2022 5
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

170 results

Results by year

Filters applied: . Clear all
Page 1
Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease.
Zeiser R, Polverelli N, Ram R, Hashmi SK, Chakraverty R, Middeke JM, Musso M, Giebel S, Uzay A, Langmuir P, Hollaender N, Gowda M, Stefanelli T, Lee SJ, Teshima T, Locatelli F; REACH3 Investigators. Zeiser R, et al. N Engl J Med. 2021 Jul 15;385(3):228-238. doi: 10.1056/NEJMoa2033122. N Engl J Med. 2021. PMID: 34260836 Clinical Trial.
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease.
Zeiser R, von Bubnoff N, Butler J, Mohty M, Niederwieser D, Or R, Szer J, Wagner EM, Zuckerman T, Mahuzier B, Xu J, Wilke C, Gandhi KK, Socié G; REACH2 Trial Group. Zeiser R, et al. N Engl J Med. 2020 May 7;382(19):1800-1810. doi: 10.1056/NEJMoa1917635. Epub 2020 Apr 22. N Engl J Med. 2020. PMID: 32320566 Clinical Trial.
Improved Long-Term Net Survival after Allogeneic Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies over Two Decades.
Ohbiki M, Ito Y, Inamoto Y, Miyamura K, Uchida N, Fukuda T, Fujiwara H, Nishida T, Hayashi M, Tanaka M, Kawakita T, Ikegame K, Katayama Y, Ara T, Ichinohe T, Kiyoi H, Matsuo K, Atsuta Y. Ohbiki M, et al. Among authors: miyamura k. Transplant Cell Ther. 2023 Dec;29(12):768.e1-768.e10. doi: 10.1016/j.jtct.2023.09.010. Epub 2023 Sep 21. Transplant Cell Ther. 2023. PMID: 37739224
[Increasing options of stem cell sources].
Miyamura K. Miyamura K. Rinsho Ketsueki. 2013 Feb;54(2):145-55. Rinsho Ketsueki. 2013. PMID: 23470821 Review. Japanese. No abstract available.
Neurolymphomatosis in follicular lymphoma: an autopsy case report.
Ando T, Kamoshita S, Riku Y, Ito A, Ozawa Y, Miyamura K, Fujino M, Ito M, Goto Y, Mano K, Akagi A, Miyahara H, Katsuno M, Yoshida M, Iwasaki Y. Ando T, et al. Among authors: miyamura k. Neuropathology. 2022 Aug;42(4):295-301. doi: 10.1111/neup.12807. Epub 2022 May 23. Neuropathology. 2022. PMID: 35607714
[Bacillus cereus bacteremia in patients with hematological disorders].
Nakashima M, Osaki M, Goto T, Kagaya Y, Kawashima N, Morishita T, Ozawa Y, Miyamura K. Nakashima M, et al. Among authors: miyamura k. Rinsho Ketsueki. 2021;62(3):157-162. doi: 10.11406/rinketsu.62.157. Rinsho Ketsueki. 2021. PMID: 33828007 Japanese.
170 results